Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
19 September 2025The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use
The WHO’s AWaRe classification, introduced in 2017, is a global tool to optimize antibiotic use and curb resistance. It groups antibiotics into Access, Watch, and Reserve categories based on their resistance impact, guiding stewardship at all levels. Updated biennially, it helps set targets and monitor antibiotic use and policy outcomes.
Read more... -
16 September 2025Irresistible: developing new solutions for antimicrobial resistant STIs
This report warns that antimicrobial resistance (AMR) is a growing public health threat, particularly for sexually transmitted infections (STIs) such as gonorrhoea, Mycoplasma genitalium and trichomoniasis. Gonorrhoea is already classified as multidrug resistant, while the others are showing increasing resistance. Without better diagnostics and vaccines, even new antimicrobials will quickly face resistance, leaving few effective […]
Read more... -
09 September 2025The Take 5 Campaign: Effects of an Intervention to Promote Five-Day Durations of Antibiotic Therapy for Common Infections in Urgent Care
This quasi-experimental study evaluated the Take 5 campaign, an intervention promoting five-day antibiotic courses for common infections in urgent care. Conducted at two centers (2017–2023), it targeted skin infections, UTIs, sinusitis, otitis media, pneumonia, and COPD exacerbations. The campaign led to an immediate 10.7% rise in ≤5-day prescriptions and a continued monthly increase, raising adherence […]
Read more...
More news related to Healthy patients
